Sonic Healthcare USA Inc. announced Aug. 22 it has acquired Cairo Diagnostics LLC, a provider of hematology oncology diagnostics based in White Plains, New York and with a second laboratory in Woodcliff Lake. Financial terms were not disclosed.
Sonic, the U.S. operating division of medical diagnostics company Sonic Healthcare Limited, plans to integrate Cairo’s medically led test menu and infrastructure into its national network, supported by Sonic’s logistics, payer contracting and commercial organization.
Founded by hematopathologist Dr. Sherif Ibrahim in 2013, Cairo has been recognized for its integrated approach to oncology testing. Cairo Diagnostics provides personalized diagnostic reports by combining histopathology, molecular diagnostics, cytogenetics, flow cytometry, and immunohistochemistry under one roof. This approach is designed to reduce delays often encountered when testing is spread across multiple laboratories, supporting oncologists with more complete information to guide timely treatment decisions.
“This acquisition reflects Sonic’s commitment to medical leadership in practice, not just in words,” said Dr. Cory A. Roberts, CEO of Sonic. “By bringing Cairo’s integrated oncology platforms into Sonic’s network, we expect to access, service and support oncologists nationwide — expanding the reach of Cairo’s expertise while strengthening SHUSA’s (Sonic’s) capabilities in high-complexity oncology diagnostics.”
“By combining Cairo’s comprehensive menu with SHUSA’s nationwide infrastructure, we can deliver faster, more complete answers to care teams,” added Dr. Mohammed Salama, chief medical officer, Sonic Healthcare USA Inc. “This acquisition positions us to expand into areas of innovation — including liquid biopsy and other emerging technologies — that will help anticipate the evolving needs of oncology care.”
Ibrahim emphasized the shared focus on quality and scalability.
“For over a decade, Cairo Diagnostics has focused on bringing essential tests together under one roof and delivering results in days, not weeks. Becoming part of Sonic Healthcare USA will allow that same quality and speed in oncology testing to reach providers and patients nationwide — while maintaining the responsive and personal approach that has defined us from the start.”
Before founding Cairo, Ibrahim previously served in academic medicine at NYU, Memorial Sloan-Kettering, and MD Anderson Cancer Center.
Following closing, Sonic expects the acquired Cairo capabilities to be offered as in-network to a substantial share of covered lives. Cairo’s regional presence in the New York-New Jersey-Connecticut area will be scaled nationally through Sonic’s sales organization, payer relationships and specimen logistics expertise.
For patients, the acquisition is expected to expand access to advanced oncology diagnostics. For physicians, it offers a single source for integrated results with a track record of fast turnaround times. Â
Sonic Healthcare USA, Inc. is the U.S. operating division of Sonic Healthcare Limited, one of the world’s largest medical diagnostics companies. SHUSA provides clinical and anatomic pathology services through a nationwide network guided by medical leadership and local practice models.
